Rubel v. Pfizer Inc.

By In the United States Court of Appeals for the Seventh Circuit

Rubel v. Pfizer Inc. - In the United States Court of Appeals for the Seventh Circuit
  • Release Date: 2004-03-24
  • Genre: Law

Description

Janet Rubel filed in state court a complaint alleging that Pfizer and Warner-Lambert had improperly promoted the prescription drug Neurontin for off-label uses (i.e., medical conditions not covered by the Food and Drug Administrations finding that the drug is safe and effective). She sought restitution of the amounts she had paid for the drug, an injunction forbidding future promotion for off-label uses, disgorgement of all profits Pfizer had made from these sales, and punitive damages. Rubel also sought to represent a national class including everyone who had purchased Neurontin for off-label uses. Consistent with Illinois practice, the complaint did not attempt to estimate the amount in controversy.